Wells Fargo & Company Bio Path Holdings Inc Transaction History

Wells Fargo & Company

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$0.36 - $0.75 $3 - $8	11 Added 13.1%	95 $0
Q3 2023 Nov 13, 2023	BUY	$0.36 - $1.78 $9 - $48	27 Added 47.37%	84 $0
Q2 2023 Aug 15, 2023	BUY	$1.22 - $2.13 $2 - $4	2 Added 3.64%	57 $0
Q1 2023 May 12, 2023	BUY	$1.39 - $2.26 $8 - $13	6 Added 12.24%	55 $0
Q4 2022 Feb 13, 2023	BUY	$1.32 - $69.2 $1 - $69	1 Added 2.08%	49 $0
Q2 2022 Aug 12, 2022	BUY	$2.83 - $4.02 $11 - $16	4 Added 9.09%	48 $0
Q4 2021 Feb 14, 2022	BUY	$3.77 - $5.24 $3 - $5	1 Added 2.33%	44 $0
Q3 2021 Nov 15, 2021	SELL	$5.13 - $6.78 $10 - $13	-2 Reduced 4.44%	43 $0
Q1 2021 May 13, 2021	BUY	$3.63 - $11.77 $54 - $176	15 Added 50.0%	45 $0
Q4 2020 Feb 09, 2021	BUY	$3.21 - $5.26 $22 - $36	7 Added 30.43%	30 $0
Q3 2020 Nov 05, 2020	BUY	$3.85 - $5.5 $7 - $11	2 Added 9.52%	23 $0
Q2 2020 Aug 13, 2020	SELL	$4.15 - $6.04 $153 - $223	-37 Reduced 63.79%	21 $0
Q1 2020 May 14, 2020	BUY	$3.07 - $8.26 $178 - $479	58 New	58 $0

Ticker BPTH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,160,160
Market Cap $5.51M
Description
Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.